Vertaling van "public health in accordance with article " (Nederlands → Frans) :

Applications for already notified homeopathic medicines will have to be submitted in line with a timetable which will be set by the Minister of Public Health in accordance with article 14 of the royal decree of 23 June 1999.
Applications for already notified homeopathic medicines will have to be submitted in line with a timetable which will be set by the Minister of Public Health in accordance with article 14 of the royal decree of 23 June 1999.

Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)
Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)

BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council
BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council

With a previous attempted suicide constituting the most important risk factor for a renewed attempt and with a minority of patients seeking professional help after a first attempt (according to the WHO, only one in four is admitted to hospital), it is absolutely vital that as many health professionals as possible (doctors, specialists, pharmacists, home care nurses, etc) should receive adequate training to recognise the risks of suicide and refer the patient to the appropriate health professional.
Si une tentative de suicide antérieure est le facteur de risque le plus important pour une nouvelle tentative de suicide, et si une minorité de patients font appel à l’aide professionnelle après une première tentative (seulement 1 sur 4 est pris en charge par le milieu hospitalier selon l’OMS), c’est une condition absolue qu’un maximum de prestataires de soins (médecins, spécialistes, pharmaciens, infirmières à domicile, etc) soient formés de façon adéquate pour reconnaître les risques de suicide et pour orienter vers le prestataire de soins professionnel adéquat.

BAPCOC (with FPS Public Health) Board for biosafety (with WIV - ISP and the Biosafety and Biotechnology Service) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Professional Ethics Committee (with FPS Public Health - DG Animals - Plants - Foodstuffs) Strategic unit/RIZIV - INAMI
BAPCOC (with FPS Public Health) Board for biosafety (with WIV - ISP and the Biosafety and Biotechnology Service) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Professional Ethics Committee (with FPS Public Health - DG Animals - Plants - Foodstuffs) Strategic unit/RIZIV - INAMI

National mental health policies that should strengthen the value of mental health, recognise and try to solve the great problems affecting mental health in all layers of society: refugees, disaster victims, those marginalised from society, the mentally handicapped, very old and disabled individuals, abused women and children, as well as financially impoverished people. In order to do so, it is necessary to adapt the organisation of the Community accordingly (with regard to mass media, health services, other organisations, industry and business, legislation).
Politiques nationales de santé mentale qui doivent renforcer la valeur de la santé mentale, reconnaître et tenter de résoudre les grands problèmes affectant la santé mentale dans tous les secteurs de la société: réfugiés, victimes de catastrophes, exclus sociaux, handicapés mentaux, personnes très âgées et infirmes, femmes et enfants victimes de mauvais traitement, ainsi que les personnes financièrement démunies; et à cette fin, adapter l’organisation de la Communauté (mass media, services de santé, autres organisations, industries et commerces, législation).

Figure 2 Percentage of the population (aged 15 and over) with recent psychological difficulties, according to the dichotomised GHQ-12 score [2+], by age and gender. Health Survey, Belgium, 2004.
Figure 2: Pourcentage de la population (de 15 ans et plus) ayant des difficultés psychologiques récentes, selon le score au GHQ-12 dichotomisé à [2+], par âge et par sexe, Enquête de Santé, Belgique, 2004.

Consultation platform with FAVV - AFSCA, FPS Public Health e-MED (electronic prescription of medicines) (with FPS Public e-MED (electronic prescription of medicines) (with FPS Public
Consultation platform with FAVV - AFSCA, FPS Public Health e-MED (electronic prescription of medicines) (with FPS Public e-MED (electronic prescription of medicines) (with FPS Public

and Public Health Minister’s office “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS
and Public Health Minister’s office “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS

The Federal Agency for Medicines and Health Products faced numerous challenges in 2007: constructing a dynamic and efficient public service thanks to the newly acquired autonomy and transparent and professional management; developing into an institution with a national and international reputation; and becoming a learning organisation, capable of meeting people’s expectations with regard to public health.
The Federal Agency for Medicines and Health Products faced numerous challenges in 2007: constructing a dynamic and efficient public service thanks to the newly acquired autonomy and transparent and professional management; developing into an institution with a national and international reputation; and becoming a learning organisation, capable of meeting people’s expectations with regard to public health.